Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ 23,421,355 $ (3,183,297)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on related party investment – TNF (21,395,734) 0
Stock-based compensation 222,677 0
Warrant issuance costs 0 913,640
Change in fair value of warrant liability (2,084,000) 1,452,000
Change in fair value of derivative liability (1,204,000) 530,000
Change in fair value of convertible note receivable (245,000) 0
Change in fair value of warrant asset – Femasys 1,510,000 0
Change in fair value of investment – TNF (724,266) 0
Change in assets and liabilities:    
Decrease in prepaid expenses and other current assets 19,573 19,031
Increase in accounts payable 164,582 589,849
Increase (decrease) in accrued expenses (58,484) 21,736
Net cash provided by (used in) operating activities (373,297) 342,959
Cash flows from investing activities:    
Investment in preferred stock and warrants (7,000,000) 0
Net cash used in investing activities (7,000,000) 0
Cash flows from financing activities:    
Repurchase of common stock (742,179) (26,457,324)
Proceeds from issuance of preferred stock 0 35,000,000
Payment for issuance costs related to preferred stock 0 (2,263,565)
Redemption of preferred stock (9,429,583) 0
Proceeds from warrant exercise 0 70
Net cash provided by (used in) financing activities (10,171,762) 6,279,181
Effect of currency rate exchange on cash and cash equivalents 183 451
Net increase (decrease) in cash and cash equivalents (17,544,876) 6,622,591
Cash and cash equivalents at beginning of the period 50,179,968 68,039,936
Cash and cash equivalents at end of the period 32,635,092 74,662,527
Supplemental disclosure of cash flows information:    
Cash paid during the periods for income taxes 0 1,600
Supplemental disclosure of cash flows information:    
Non-cash derivative liability at initial fair value 0 2,770,000
Non-cash warrant liability at initial fair value 0 14,127,000
Reclassification of Series B Convertible Preferred Stock and dividends to current liability 9,367,750 0
Accretion of discounts to redemption value of Series B Preferred Stock 2,148,047 3,272,033
Excise tax accrued on repurchase of common stock $ 7,421 $ 264,573